Clinical Trial: Efficacy and Safety of Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy and Sequential Adebrelimab Maintenance Therapy for Extensive-stage Small Cell Lung Cancer: A Prospective, Multicenter Phase II Study. (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy and Sequential Adebrelimab Maintenance Therapy for Extensive-stage Small Cell Lung Cancer: A Prospective, Multicenter Phase II Study.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134711

Registration Time: 2026/10/20

Type: Interventional study

Primary Sponsor: Jiangmen Central Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336480

Published by HT Digital Content Services with permission from Health Daily Digest....